Taxus Cardium Pharm Group Inc (fka CRXM)

[lovinlife1216]

Well, can't say that I am happy at all, but I must admit, CXM is doing everything they can to continue to financially support their clinicals with the latest offering. Sucks for shareholders (obviously) in the short-term. I see the next support levels around 1.15 and may buy there to average down.... again.

There is no doubt this stock will be a "gem" for someone getting in after today, but with their latest announcement to raise cash, it has gone from a short play to a long play. Darn the bad luck for all of those (including me) who got in a wee bit late on hopes of a market positive response on their phase 2b findings...